Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced third quarter ...

Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury ...

We're keeping track of all the numbers in what is set to be another busy year at AUS. Follow along with our interactive ...

Hyperscaler deals, strong ARR guidance, and solid revenue growth signal value for Nebius despite the selloff. Learn why ...

Q2 Fiscal 2026 Highlights Record royalties of $4.5 millionRecord total revenues of $16.1 millionRecord net profit of $4.5 million after a $0.4 million restructuring chargeRecord adjusted EBITDA1 of $5 ...

Dow Jones futures added 0.24% to trade above 48,450 during European hours ahead of the opening of the United States (US) ...

Bitcoin continues to trade below $105K as fear grips the market, while altcoins like Decred, Sky, and Story see modest gains ...

The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...

Tesla, Inc.’s $1T pay plan approval highlights risk. Click to see why operational woes, falling margins, and weak growth make ...

Framework to easily generate complex synthetic data pipelines by visualizing and configuring the pipeline as a computational graph. LangGraph is used as the underlying graph configuration/execution ...

Maplebear reported third-quarter financial results on Monday. The transcript from the company's earnings call has been ...

Bitcoin’s long honeymoon above $100K is over. On November 5, 2025, the market leader slid under the six-figure mark for the ...